Skip to main content
. 2015 May 26;106(6):747–756. doi: 10.1111/cas.12672

Figure 6.

Figure 6

Therapeutic responses of nude mice bearing HepG2 and H1299 tumors (n = 3–5). (a) Volume (V) changes of HepG2 tumors in three groups treated with saline, doxorubicin (DOX), or aspartate-modified DOX (Asp-DOX). (b) Volumes of HepG2 tumors in different groups after 21 days of treatment. (c) Volume changes of H1299 tumors in groups treated with saline, DOX, and Asp-DOX. (d) Volumes of H1299 tumors in different groups after 21 days of treatment.